New breast-cancer drug

Government drug-buying agency Pharmac has approved funding for a new drug for breast-cancer sufferers.

Pharmac medical director Dr Peter Moodie said exemestane would be fully funded under a deal with pharmaceutical company Pfizer.

Exemestane, an aromatase inhibitor drug, can help to block the growth of hormone-dependent tumours by lowering the amount of oestrogen hormone in the body.

Get the news delivered straight to your inbox

Receive the day’s news, sport and entertainment in our daily email newsletter

SIGN UP NOW

© Copyright 2017, NZME. Publishing Limited

Assembled by: (static) on production bpcf03 at 31 Mar 2017 03:25:27 Processing Time: 281ms